Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

BACKGROUND: This study characterises molecular effect of bevacizumab, and explores the relation of molecular and genetic markers with response to bevacizumab combined with chemoradiotherapy (CRT). METHODS: From a subset of 59 patients of 84 rectal cancer patients included in a phase II study combini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Verstraete, M, Debucquoy, A, Dekervel, J, van Pelt, J, Verslype, C, Devos, E, Chiritescu, G, Dumon, K, D'Hoore, A, Gevaert, O, Sagaert, X, Van Cutsem, E, Haustermans, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402460/
https://ncbi.nlm.nih.gov/pubmed/25867261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.93
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados